← Open Payments lookup

ALEJANDRO GIL: Open Payments

NPI 1417951963 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,243 in 48 payments from 14 companies in 2025. Trend: 2023 $2,793 · 2024 $2,844 · 2025 $2,243

Food & beverage: $2,243
CompanyPaymentsAmount
Amgen Inc.7$482
Bayer Healthcare Pharmaceuticals Inc.9$480
ABBVIE INC.6$347
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$249
Lilly USA, LLC3$167
Otsuka America Pharmaceutical, Inc.6$148
Ardelyx, Inc.4$122
Novo Nordisk Inc2$56
Boehringer Ingelheim Pharmaceuticals, Inc.2$50
Sumitomo Pharma America, Inc.2$34

Products named: Kerendia, EVENITY, CAPLYTA, OTEZLA, REXULTI, QULIPTA, UBRELVY, IBSRELA.

Industry payments across CA — which companies pay providers there.